SPDR S&P Biotech ETF Rating $87.82 +1.91 (+2.22%) Closing price 07/16/2025 04:10 PM EasternExtended Trading$87.98 +0.16 (+0.18%) As of 06:36 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock SPDR S&P Biotech ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy 2.74Holdings in XBI have an aggregate rating of Moderate Buy based on 761 analyst ratings issued in the past year covering 50 companies (78.1% of the portfolio).XBI Aggregate Price Target$87.82High Prediction$87.82Average Prediction$87.82Low Prediction$87.82Holdings in XBI have an aggregate price target of $87.82 and a range of $87.82 to $87.82 covering 50 companies (78.1% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy26 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings3.53%INSMInsmed$104.59+1.7%3.8331 of 5 stars3.00$108.07 3.3%17Insider Trade3.25%ALNYAlnylam Pharmaceuticals$322.81+3.8%4.02 of 5 stars2.80$346.13 7.2%25Trending NewsAnalyst ForecastAnalyst Revision3.03%NTRANatera$148.40-1.0%1.633 of 5 stars3.00$184.63 24.4%15Positive News3.00%BPMCBlueprint Medicines$129.28-0.1%1.1255 of 5 stars2.24$128.25 -0.8%21Positive NewsHigh Trading Volume2.95%NBIXNeurocrine Biosciences$133.48+1.7%4.4854 of 5 stars2.87$163.91 22.8%23Trending NewsAnalyst Revision2.91%EXASExact Sciences$53.67+1.3%4.687 of 5 stars2.95$70.50 31.4%222.57%INCYIncyte$69.23+1.4%4.6129 of 5 stars2.22$74.47 7.6%18Trending NewsAnalyst ForecastInsider TradeAnalyst Revision2.42%GILDGilead Sciences$109.85+0.7%4.8916 of 5 stars2.77$111.38 1.4%26Trending NewsInsider TradeOptions VolumeAnalyst Revision2.41%UTHRUnited Therapeutics$298.16+1.7%4.988 of 5 stars2.69$383.08 28.5%13Positive NewsInsider Trade2.36%AMGNAmgen$299.02+2.2%4.3971 of 5 stars2.35$307.82 2.9%23Trending NewsAnalyst Revision2.31%BIIBBiogen$128.46+0.8%4.9058 of 5 stars2.38$188.48 46.7%32Trending NewsInsider TradeAnalyst Revision2.27%VRTXVertex Pharmaceuticals$469.55+1.2%4.2941 of 5 stars2.54$511.71 9.0%28Trending NewsAnalyst ForecastAnalyst Revision2.23%ABBVAbbVie$190.53+2.2%4.8424 of 5 stars2.81$211.29 10.9%27Trending NewsAnalyst Revision2.19%EXELExelixis$44.81+1.7%4.7742 of 5 stars2.52$45.28 1.0%21Analyst Forecast2.01%MDGLMadrigal Pharmaceuticals$344.97+10.9%3.7534 of 5 stars2.89$420.63 21.9%9News CoveragePositive NewsGap UpHigh Trading Volume1.99%BBIOBridgeBio Pharma$47.10+0.3%4.6331 of 5 stars3.00$61.20 29.9%15Trending NewsAnalyst ForecastAnalyst Revision1.88%MRNAModerna$32.06+1.5%4.3544 of 5 stars2.04$46.61 45.4%25Analyst Revision1.88%REGNRegeneron Pharmaceuticals$547.930.0%4.813 of 5 stars2.80$814.57 48.7%251.70%BMRNBioMarin Pharmaceutical$58.39+3.1%4.985 of 5 stars2.75$93.78 60.6%24News CoveragePositive NewsAnalyst Forecast1.55%IONSIonis Pharmaceuticals$42.77+1.8%4.5441 of 5 stars2.76$57.13 33.6%171.54%TGTXTG Therapeutics$38.84+2.3%3.5146 of 5 stars2.80$43.80 12.8%51.53%RVMDRevolution Medicines$38.40+1.6%4.5351 of 5 stars3.00$68.91 79.5%11Analyst Forecast1.52%CRSPCRISPR Therapeutics$55.14+4.6%3.2536 of 5 stars2.53$71.75 30.1%17Analyst Revision1.38%HALOHalozyme Therapeutics$58.01+2.5%4.8461 of 5 stars2.17$62.70 8.1%12Positive NewsAnalyst Forecast1.34%ROIVRoivant Sciences$11.54+1.6%2.6267 of 5 stars3.25$16.50 43.0%4Positive News1.23%SWTXSpringWorks Therapeutics$46.991.6096 of 5 stars2.13$52.57 11.9%8News Coverage1.13%CYTKCytokinetics$38.68+1.8%4.035 of 5 stars2.93$70.92 83.4%15Insider Trade1.13%VKTXViking Therapeutics$31.63+3.0%4.6241 of 5 stars3.00$87.15 175.5%14Positive NewsUpcoming EarningsGap Up1.11%SMMTSummit Therapeutics$28.27+16.1%1.9557 of 5 stars2.79$34.67 22.6%14Gap Down1.07%ACADACADIA Pharmaceuticals$22.55+2.5%4.0926 of 5 stars2.71$27.88 23.6%17Analyst Revision1.03%ALKSAlkermes$29.20+1.2%4.7914 of 5 stars2.83$40.92 40.1%12Upcoming EarningsAnalyst Forecast1.02%PCVXVaxcyte$36.57+3.7%1.7837 of 5 stars3.10$136.50 273.3%10Positive News1.00%RNAAvidity Biosciences$33.53+5.8%2.3457 of 5 stars3.06$66.35 97.9%170.95%AKROAkero Therapeutics$53.60+3.6%3.5268 of 5 stars3.00$82.50 53.9%60.93%ADMAADMA Biologics$17.69-1.6%3.8556 of 5 stars3.33$27.67 56.4%3Positive News0.90%SRRKScholar Rock$41.15+6.2%3.0841 of 5 stars3.14$42.67 3.7%70.90%NUVLNuvalent$85.45+3.0%3.3331 of 5 stars3.17$119.60 40.0%120.87%ACLXArcellx$70.70+3.7%2.5052 of 5 stars3.07$111.23 57.3%15Positive News0.87%SLNOSoleno Therapeutics$85.52+2.3%4.5903 of 5 stars3.09$108.70 27.1%110.84%RYTMRhythm Pharmaceuticals$91.44+2.3%3.1648 of 5 stars3.07$91.00 -0.5%15Analyst Revision0.81%TWSTTwist Bioscience$36.69+0.9%4.2627 of 5 stars2.70$50.40 37.4%100.78%RAREUltragenyx Pharmaceutical$27.31+0.4%4.4544 of 5 stars2.93$83.64 206.3%14Trending NewsAnalyst ForecastAnalyst RevisionHigh Trading Volume0.76%AGIOAgios Pharmaceuticals$39.99+2.0%4.3958 of 5 stars2.71$58.60 46.5%7Analyst Revision0.75%KRYSKrystal Biotech$150.08+1.6%4.5569 of 5 stars3.00$213.75 42.4%9Trending NewsInsider TradeAnalyst Revision0.75%APLSApellis Pharmaceuticals$19.75+2.1%4.316 of 5 stars2.62$39.84 101.7%21Trending NewsAnalyst ForecastInsider TradeAnalyst Revision0.73%CRNXCrinetics Pharmaceuticals$31.90+0.2%3.4539 of 5 stars2.80$69.50 117.9%100.71%RXRXRecursion Pharmaceuticals$5.39+3.3%1.8594 of 5 stars2.33$7.00 29.9%60.70%ARWRArrowhead Pharmaceuticals$18.30+3.8%3.7496 of 5 stars2.75$43.71 138.9%8News CoveragePositive News0.69%VCYTVeracyte$25.17-0.3%3.5566 of 5 stars2.70$40.90 62.5%100.68%PTCTPTC Therapeutics$48.14+0.8%4.4702 of 5 stars2.67$65.00 35.0%15Analyst Revision This page (NYSEARCA:XBI) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share SPDR S&P Biotech ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBI Stock Alerts